Synthetic matrix metalloproteinase inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse model

Prostate

Volumn 35, Issue 4, 1998, Pages 248-254

  Knox, J David ^a   Bretton, Louis ^b   Lynch, Tamara ^b   Bowden, G Tim ^b   Nagle, Ray B ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Batimastat; DU 145; Matrigel; Matrilysin

Indexed keywords

BATIMASTAT; MATRIGEL; MATRILYSIN; MATRIX METALLOPROTEINASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; HUMANS; MALE; METALLOENDOPEPTIDASES; MICE; MICE, SCID; NEOPLASM INVASIVENESS; PHENYLALANINE; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; THIOPHENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032103978     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<248::AID-PROS3>3.0.CO;2-C     Document Type: Article

References (24)

1. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 1991;51:5054-5059.
2. Schmitt M, Janicke F, Graeff H: Tumor-associated proteases. Fibrinolysis [Suppl] 1992;4:3-26.
3. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Gigioni WF: Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-246.
4. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 1991:51:439-444.
5. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr: Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-1441.
6. Basset P, Wolf C, Rouyer N, Bellocq JP, Rio MC, Chambon P: Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 1994;74:1045-1049.
7. Knox JD, Wolf C, McDaniel K, Clark V, Loriot M, Bowden GT, Nagle RB: Matrilysin expression in human prostate carcinoma. Mol Carcinog 1996;15:57-63.
8. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989;243:947-950.
9. Noel AC, Lefebvre O, Maquoi E, VanHoorde L, Chenard MP, Mareel M, Foidart JM, Basset P, Rio MC: Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 1996;97: 1924-1930.
10. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM: Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994; 54:4805-1812.
11. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT: Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 1993;3:417-422.
12. Knox JD, Mack CF, Powell WC, Bowden GT, Nagle RB: Prostate tumor cell invasion: A comparison of orthotopic and ectopic models. Invasion Metastasis 1993;13:325-331.
13. Kohn EC, Liotta LA: Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 1995;55: 1856-1862.
14. Botos I, Scapozza L, Zhang D, Liotta LA, Meyer EF: Batimistat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc Natl Acad Sci USA 1996;93:2749-2754.
15. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR: A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-2091.
16. Chirivi RGS, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R: Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994;58:460-464.
17. Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM: Matrix Metalloproteinase inhibitor BB-94 (batimistat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 1994;54:4726-4728.
18. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD: Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimistat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995;55:3629-3633.
19. Taraboletti G, Garofalo A, Bellotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, Giavazzi R: Inhibition of angiogenesis and murine hemangioma growth by batimistat, a synthetic inhibitor of matrix Metalloproteinases. J Natl Cancer Inst 1995;87:293-298.
20. Sledge GW Jr, Qulali M, Goulet R, Bone EA, Fife R: Effect of matrix metalloproteinase inhibitor batimistat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 1995;87:1546-1550.
21. Folman J, Klagsbrun M: Angiogenic factors. Science 1987;235: 442-447.
22. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991:63:327-336.
23. DeLisser HM, Chilkotowsky J, Yan HC, Daise ML, Buck CA, Albelda SM: Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Cell Biol 1994;124:195-203.
24. Knox JD, Cress AE, Clark V, Manriquez L, Affinito K-S, Dalkin BL, Nagle RB: Differential expression of extracellular matrix molecules and the α-integrins in the normal and neoplastic prostate. Am J Pathol 1994;145:167-174.